Skip to content

Homeopathic treatment of neck pain

Efficacy of Individualized Homoeopathic Medicines in Treatment of Cervical Spondylosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016156
Enrollment
140
Registered
2018-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: Individualised homeopathic medicine in centesimal potency: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies. Each dose will be consistin
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from good manufacturing practice (GMP)-certified firm. Along with medicines, the interventi
dosage and repetition depending upon individual requirement of the cases. Along with identical placebo, the intervention arm will receive physiotherapy and lifestyle modifications. Duration of therapy

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosed cases of cervical spondylosis (ICD M47.8) 2) Age 18 to 65 years 3) Both sexes 4) Literate patients; able to read English and/or Bengali 5) Patients giving written consent to participate

Exclusion criteria

Exclusion criteria: 1) Patients having severe degenerative changes (e.g. disc prolapse, myelopathy, radiculopathy etc) as suggested by radiological findings 2) Patients undergoing homoeopathic treatment for any chronic disease within last 3 months 3) Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure 4) Pregnancy and lactation 5) Substance abuse and/or dependence 6) Self-reported immune-compromised state

Design outcomes

Primary

MeasureTime frame
0-10 Numeric Rating Scales measuring intensity of pain, stiffness, numbness, tingling, weakness and vertigoTimepoint: At baseline, every month up to month 3

Secondary

MeasureTime frame
Neck Disability Index (NDI) measuring quality of life related to cervical spondylosisTimepoint: At baseline, every month up to month 3

Countries

India

Contacts

Public ContactNetai Chand Bhowmick

National Institute of Homoeopathy

nitai.ch.bhowmik@gmail.com8001384666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026